Patent US5698402A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5698402A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods for diagnosing benign prostatic hyperplasia

Assignee: Dianon Systems Inc
•
Filing: 1995-02-23
•
Granted: 1997-12-16
•
Expires: 2015-02-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to a method for diagnosing benign prostatic hyperplasia (BPH) in a male human patient without requiring a biopsy. The total prostate specific antigen (PSA) level in the blood or serum of the patient is measured. If the patient has a total PSA level of between 2.5 ng/ml, (4.0 ng/ml for those 60 years or over), and 10.0 ng/ml, then the free PSA level in the blood or serum of the patient is measured. The proportion of free PSA to total PSA is calculated. If this proportion is equal to or greater than about 25%, then the patient is diagnosed as having BPH.

Inventors

  • 👤 Albert A. Luderer
  • 👤 Grant D. Carlson
  • 👤 Robert P. Thiel
  • 👤 Thomas F. Soriano
  • 👤 William J. Kramp

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 11:45
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/68; G01N33/53; G01N33/575; G01N33/57555

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 106 words
A method for diagnosing benign prostatic hyperplasia (BPH) in a male human patient under 60 years old without requiring a prostate biopsy comprising: a) measuring the total prostate specific antigen (PSA) level in the blood or serum of the patient; b) measuring the free PSA level in the blood or serum of a patient only if said patient has a total PSA level of between 2.5 ng/ml and 10.0 ng/ml; c) calculating the proportion of free PSA to total PSA; and d) diagnosing the patient as having BPH if the calculated proportion of free PSA to total PSA is equal to or greater than about 25%.
Claim 2
Independent Claim 106 words
A method for diagnosing benign prostatic hyperplasia (BPH) in a male human patient under 60 years old without requiring a prostate biopsy comprising: a) measuring the total prostate specific antigen (PSA) level in the blood or serum of the patient; b) measuring the free PSA level in the blood or serum of a patient only if said patient has a total PSA level of between 2.5 ng/ml and 10.0 ng/ml; c) calculating the proportion of free PSA to total PSA; and d) diagnosing the patient as having BPH if the calculated proportion of free PSA to total PSA is equal to or greater than about 25%.
Claim 3
Independent Claim 107 words
A method for diagnosing benign prostatic hyperplasia (BPH) in a male human patient at least 60 years old without requiring a prostate biopsy comprising: a) measuring the total prostate specific antigen (PSA) level in the blood or serum of the patient; b) measuring the free PSA level in the blood or serum of a patient only if said patient has a total PSA level of between 4.0 ng/ml and 10.0 ng/ml; c) calculating the proportion of free PSA to total PSA; and d) diagnosing the patient as having BPH if the calculated proportion of free PSA to total PSA is equal to or greater than about 25%.
Claim 4
Independent Claim 107 words
A method for diagnosing benign prostatic hyperplasia (BPH) in a male human patient at least 60 years old without requiring a prostate biopsy comprising: a) measuring the total prostate specific antigen (PSA) level in the blood or serum of the patient; b) measuring the free PSA level in the blood or serum of a patient only if said patient has a total PSA level of between 4.0 ng/ml and 10.0 ng/ml; c) calculating the proportion of free PSA to total PSA; and d) diagnosing the patient as having BPH if the calculated proportion of free PSA to total PSA is equal to or greater than about 25%.

References Cited (Backward Citations)

US5501983A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-12-15 2001-06-16 2001-12-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-12-15 2005-06-16 2005-12-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-12-15 2009-06-16 2009-12-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag